These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 26374074)

  • 1. Molecular Pathways: At the Crossroads of Cancer Epigenetics and Immunotherapy.
    Maio M; Covre A; Fratta E; Di Giacomo AM; Taverna P; Natali PG; Coral S; Sigalotti L
    Clin Cancer Res; 2015 Sep; 21(18):4040-7. PubMed ID: 26374074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging epigenetics to enhance the efficacy of immunotherapy.
    Licht JD; Bennett RL
    Clin Epigenetics; 2021 May; 13(1):115. PubMed ID: 34001289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic modulation of solid tumors as a novel approach for cancer immunotherapy.
    Sigalotti L; Coral S; Fratta E; Lamaj E; Danielli R; Di Giacomo AM; Altomonte M; Maio M
    Semin Oncol; 2005 Oct; 32(5):473-8. PubMed ID: 16210088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer epigenetics: an introduction.
    Kanwal R; Gupta K; Gupta S
    Methods Mol Biol; 2015; 1238():3-25. PubMed ID: 25421652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of immune checkpoints: another target for cancer immunotherapy?
    Ali MA; Matboli M; Tarek M; Reda M; Kamal KM; Nouh M; Ashry AM; El-Bab AF; Mesalam HA; Shafei AE; Abdel-Rahman O
    Immunotherapy; 2017 Jan; 9(1):99-108. PubMed ID: 28000527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics.
    Duan YT; Sangani CB; Liu W; Soni KV; Yao Y
    Curr Top Med Chem; 2019; 19(12):972-994. PubMed ID: 31161992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetics in prostate cancer: biologic and clinical relevance.
    Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
    Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compendium of aberrant DNA methylation and histone modifications in cancer.
    Hattori N; Ushijima T
    Biochem Biophys Res Commun; 2014 Dec; 455(1-2):3-9. PubMed ID: 25194808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic Therapeutics: A New Weapon in the War Against Cancer.
    Ahuja N; Sharma AR; Baylin SB
    Annu Rev Med; 2016; 67():73-89. PubMed ID: 26768237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic alterations in cancer.
    Ilango S; Paital B; Jayachandran P; Padma PR; Nirmaladevi R
    Front Biosci (Landmark Ed); 2020 Mar; 25(6):1058-1109. PubMed ID: 32114424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetics meets immune checkpoints.
    Covre A; Coral S; Di Giacomo AM; Taverna P; Azab M; Maio M
    Semin Oncol; 2015 Jun; 42(3):506-13. PubMed ID: 25965370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
    J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-molecular modulators of cancer-associated epigenetic mechanisms.
    Itoh Y; Suzuki T; Miyata N
    Mol Biosyst; 2013 May; 9(5):873-96. PubMed ID: 23511667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of epigenetic therapies in colorectal cancer.
    Baretti M; Azad NS
    Curr Probl Cancer; 2018 Nov; 42(6):530-547. PubMed ID: 29625794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant epigenetic landscape in cancer: how cellular identity goes awry.
    Berdasco M; Esteller M
    Dev Cell; 2010 Nov; 19(5):698-711. PubMed ID: 21074720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Strategies to Boost Cancer Immunotherapies.
    Barrero MJ
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28545238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression.
    Saleh R; Toor SM; Sasidharan Nair V; Elkord E
    Front Immunol; 2020; 11():1469. PubMed ID: 32760400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics and immunotherapy: The current state of play.
    Dunn J; Rao S
    Mol Immunol; 2017 Jul; 87():227-239. PubMed ID: 28511092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Epigenetics, Tumor Immunity, and Immunotherapy.
    Cao J; Yan Q
    Trends Cancer; 2020 Jul; 6(7):580-592. PubMed ID: 32610068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.